Videos
Improving Survival, Remission Rates Among Patients With AML Treated With New Drug Combo
07/08/2020
Keith Pratz, MD, associate professor of medicine at the Abramson Comprehensive Cancer Center at University of Pennsylvania, discusses the phase III VIALE-A study that demonstrated a reduction in the risk of death in patients with AML among other positive results.
Reference:
Current Issue
October/November/December Volume 21, Issue 4, First Report Managed CareWhat's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter